Table 4b.
Group 1 | Group 2 | Group 3 | Group 4 | |
---|---|---|---|---|
UC | UC + Auto | UC + Auto + Assisted | UC + Auto + Assisted + Care Mgt | |
Characteristics | n=321 | n=349 | n=285 | n=297 |
Self Efficacy Scale, mean (sd) | 4.3 (0.8) | 4.3 (0.8) | 4.2 (0.8) | 4.3 (0.8) |
(missing) | 1 | 1 | 1 | 0 |
CRC Screening Cons Scale, mean (sd) | 1.8 (0.7) | 1.7 (0.7) | 1.9 (0.8) | 1.7 (0.7) |
(missing) | 1 | 1 | 1 | 0 |
CRC Screening Pros Scale, mean (sd) | 4.5 (0.6) | 4.6 (0.5) | 4.4 (0.6) | 4.5 (0.6) |
(missing) | 1 | 0 | 1 | 0 |
Social Influence Scale, mean (sd) | 3.7 (1.1) | 3.9 (0.9) | 3.6 (1.1) | 3.6 (1.0) |
(missing) | 5 | 8 | 10 | 8 |
Cancer Worries Scale, mean (sd) | 2.3 (0.8) | 2.2 (0.8) | 2.2 (0.7) | 2.2 (0.7) |
(missing) | 1 | 0 | 1 | 1 |
All scales range from 1 to 5, with higher scores associated with stronger endorsement of self-efficacy, screening cons, screening pros, social influence, and cancer worries.